A carregar...
Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn’s Disease
BACKGROUND AND AIMS: Vedolizumab (VDZ) is effective for Crohn’s disease (CD) but costly and is slow to produce remission. Early knowledge of whether vedolizumab is likely to succeed is valuable for physicians, patients, and insurers. METHODS: Phase 3 clinical trial data on VZD for CD were used to pr...
Na minha lista:
| Publicado no: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231370/ https://ncbi.nlm.nih.gov/pubmed/29668915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy031 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|